High-Throughput Screening of an FDA-Approved Compound Library Reveals a Novel GAS6 Receptor Agonist for Therapeutic Intervention in Septic Myocardial and microvascular Injury via Modulation of Danger-Associated Molecular Patterns
对FDA批准的化合物库进行高通量筛选,发现一种新型GAS6受体激动剂,可通过调节危险相关分子模式治疗脓毒症引起的心肌和微血管损伤。
期刊:International Journal of Biological Sciences
影响因子:8.2
doi:10.7150/ijbs.104427
Haowen Zhuang ,Chun Li ,Lingjun Wang ,Bei Zhou ,Zhijiang Guo ,Yusheng Huang ,Bo Deng ,Yulin Ouyang ,Junxiong Qiu ,Xing Chang ,Wei Wang ,Junyan Wang